Cargando…
Concurrent Hepatitis C and B Virus and Human Immunodeficiency Virus Infections Are Associated With Higher Mortality Risk Illustrating the Impact of Syndemics on Health Outcomes
BACKGROUND: Hepatitis C virus (HCV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV) infections are associated with significant mortality globally and in North America. However, data on impact of concurrent multiple infections on mortality risk are limited. We evaluated the effect of...
Autores principales: | Butt, Zahid A, Wong, Stanley, Rossi, Carmine, Binka, Mawuena, Wong, Jason, Yu, Amanda, Darvishian, Maryam, Alvarez, Maria, Chapinal, Nuria, Mckee, Geoff, Gilbert, Mark, Tyndall, Mark W, Krajden, Mel, Janjua, Naveed Z |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489531/ https://www.ncbi.nlm.nih.gov/pubmed/32964065 http://dx.doi.org/10.1093/ofid/ofaa347 |
Ejemplares similares
-
Syndemic Characterization of HCV, HBV, and HIV Co-infections in a Large Population Based Cohort Study
por: McKee, Geoffrey, et al.
Publicado: (2018) -
Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada
por: Binka, Mawuena, et al.
Publicado: (2018) -
Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study
por: Wilton, James, et al.
Publicado: (2020) -
Elevated risk of colorectal, liver, and pancreatic cancers among HCV, HBV and/or HIV (co)infected individuals in a population based cohort in Canada
por: Darvishian, Maryam, et al.
Publicado: (2021) -
Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy
por: Janjua, Naveed Z., et al.
Publicado: (2019)